Children and adolescents with cancer often undergo intensive chemotherapy treatment to
obtain remission and long-term survival. The pursuit of successful treatment outcomes may …

Children and adolescents receiving treatment for cancer experience multiple symptoms as a
consequence of their disease and its treatment that interfere with the child's quality of life …

Background: Empirically derived and tested models are necessary to develop effective,
holistic interventions to improve positive health outcomes in adolescents and young adults …

Management of symptom-related distress is an important area of pediatric oncology nursing.
Participants who attended the Children's Oncology Group (COG) State of the Science …

Background: Recognizing and addressing illness-related distress has long been a priority
for pediatric oncology nurses and the Children's Oncology Group. Although symptoms are …

Background Resilience is a protective factor in healthy aging, helping to maintain and
recover physical and mental functions. The Resilience in Illness Model has proven effective …

Background Parents of adolescents and young adults (AYAs) with cancer offer primary
support to their children and often experience their own high levels of distress, affecting …

PROBLEM IDENTIFICATION: Pediatric oncology phase 1 clinical trials (P1Ts) are essential
to developing new anticancer therapies; however, they raise complex ethical concerns …

In contrast to other Children's Oncology Group (COG) committees, the COG nursing
discipline is unique in that it provides the infrastructure necessary for nurses to support COG …

Background Blinatumomab is an immunotherapy agent used in pediatric oncology for the
treatment of B-lineage acute lymphoblastic leukemia. Administration of blinatumomab, via …